Catalyst Wire Dossier Catalyst Wire Dossier

EMBLOK EPS

· Emblok, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for EMBLOK EPS, covering 2025-08-06 to 2025-08-19. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Safety and Effectiveness of the EMBLOK EPS Compared With No Cerebral Embolic Protection During TAVR [NA]

See pricing